PBH
Income statement / Annual
Last year (2024), Prestige Consumer Healthcare Inc.'s total revenue was $1.13 B,
a decrease of 0.21% from the previous year.
In 2024, Prestige Consumer Healthcare Inc.'s net income was $209.34 M.
See Prestige Consumer Healthcare Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$1.13 B
|
$1.13 B
|
$1.09 B
|
$943.37 M
|
$963.01 M
|
$975.78 M
|
$1.04 B
|
$882.06 M
|
$806.25 M
|
$714.62 M
|
| Cost of Revenue |
$500.91 M |
$502.43 M |
$466.17 M |
$395.89 M |
$410.79 M |
$420.20 M |
$464.67 M |
$381.77 M |
$339.04 M |
$308.40 M |
| Gross Profit |
$624.45 M |
$625.29 M |
$620.65 M |
$547.47 M |
$552.22 M |
$555.58 M |
$576.51 M |
$500.29 M |
$467.21 M |
$406.22 M |
| Gross Profit Ratio |
0.55 |
0.55 |
0.57 |
0.58 |
0.57 |
0.57 |
0.55 |
0.57 |
0.58 |
0.57 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$106.15 M
|
$107.35 M
|
$108.52 M
|
$85.54 M
|
$89.11 M
|
$89.76 M
|
$184.93 M
|
$89.14 M
|
$72.42 M
|
$81.27 M
|
| Selling & Marketing
Expenses |
$153.32 M
|
$145.06 M
|
$157.34 M
|
$140.59 M
|
$147.19 M
|
$143.09 M
|
$147.29 M
|
$128.36 M
|
$110.80 M
|
$99.65 M
|
| Selling, General &
Administrative Expenses |
$259.47 M
|
$252.42 M
|
$265.86 M
|
$226.13 M
|
$236.31 M
|
$232.85 M
|
$332.21 M
|
$217.50 M
|
$183.22 M
|
$180.92 M
|
| Other Expenses |
$22.55 M |
$25.08 M |
$24.87 M |
$23.94 M |
$24.76 M |
-$476,000.00 |
$28.43 M |
$25.35 M |
$23.68 M |
$17.74 M |
| Operating Expenses |
$282.02 M |
$277.49 M |
$290.73 M |
$250.07 M |
$261.07 M |
$259.90 M |
$360.64 M |
$242.85 M |
$206.90 M |
$198.66 M |
| Cost And Expenses |
$782.93 M |
$779.92 M |
$756.89 M |
$645.96 M |
$671.86 M |
$680.10 M |
$825.31 M |
$624.63 M |
$545.93 M |
$507.06 M |
| Interest Income |
$0.00 |
$69.16 M |
$64.29 M |
$82.33 M |
$342,000.00 |
$217,000.00 |
$388,000.00 |
$203,000.00 |
$162,000.00 |
$92,000.00 |
| Interest Expense |
$67.16 M |
$69.16 M |
$64.29 M |
$82.33 M |
$96.57 M |
$105.30 M |
$106.27 M |
$93.55 M |
$85.32 M |
$81.33 M |
| Depreciation &
Amortization |
$30.68 M
|
$38.94 M
|
$38.80 M
|
$37.25 M
|
$37.78 M
|
$31.78 M
|
$33.43 M
|
$25.79 M
|
$23.68 M
|
$17.74 M
|
| EBITDA |
$373.10 M
|
$14.19 M
|
$351.61 M
|
$310.38 M
|
$325.50 M
|
$327.46 M
|
$355.72 M
|
$304.46 M
|
$266.18 M
|
$226.52 M
|
| EBITDA Ratio |
0.33 |
0.34 |
0.33 |
0.35 |
0.33 |
0.34 |
0.24 |
0.32 |
0.35 |
0.32 |
| Operating Income Ratio
|
0.3
|
0.31
|
0.3
|
0.32
|
0.3
|
0.07
|
0.21
|
0.23
|
0.32
|
0.29
|
| Total Other
Income/Expenses Net |
-$66.40 M
|
-$71.50 M
|
-$67.46 M
|
-$93.29 M
|
-$100.00 M
|
-$105.56 M
|
-$108.39 M
|
-$94.79 M
|
-$103.13 M
|
-$80.10 M
|
| Income Before Tax |
$276.03 M |
-$93.92 M |
$262.46 M |
$204.11 M |
$191.15 M |
-$38.06 M |
$107.09 M |
$110.85 M |
$157.19 M |
$127.46 M |
| Income Before Tax Ratio
|
0.25
|
-0.08
|
0.24
|
0.22
|
0.2
|
-0.04
|
0.1
|
0.13
|
0.19
|
0.18
|
| Income Tax Expense |
$66.69 M |
-$11.61 M |
$57.08 M |
$39.43 M |
$48.87 M |
-$2.26 M |
-$232.48 M |
$41.46 M |
$57.28 M |
$49.20 M |
| Net Income |
$209.34 M |
-$82.31 M |
$205.38 M |
$164.68 M |
$142.28 M |
-$35.80 M |
$339.57 M |
$69.40 M |
$99.91 M |
$78.26 M |
| Net Income Ratio |
0.19 |
-0.07 |
0.19 |
0.17 |
0.15 |
-0.04 |
0.33 |
0.08 |
0.12 |
0.11 |
| EPS |
4.21 |
-1.65 |
4.09 |
3.28 |
2.81 |
-0.69 |
6.34 |
1.31 |
1.89 |
1.5 |
| EPS Diluted |
4.17 |
-1.65 |
4.04 |
3.25 |
2.78 |
-0.69 |
6.34 |
1.3 |
1.88 |
1.49 |
| Weighted Average Shares
Out |
$49.76 M
|
$49.88 M
|
$50.26 M
|
$50.21 M
|
$50.72 M
|
$51.88 M
|
$53.10 M
|
$52.98 M
|
$52.75 M
|
$52.17 M
|
| Weighted Average Shares
Out Diluted |
$50.18 M
|
$49.89 M
|
$50.84 M
|
$50.61 M
|
$51.14 M
|
$52.07 M
|
$53.53 M
|
$53.36 M
|
$53.14 M
|
$52.67 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
